Fig. 3.
Proportion of patients on tenofovir-based regimens, by year and HBsAg status in ten sub-Saharan African countries, 2010–2012. Others: HbsAg-negative or not screened
Proportion of patients on tenofovir-based regimens, by year and HBsAg status in ten sub-Saharan African countries, 2010–2012. Others: HbsAg-negative or not screened